Enhancing Competence Through Competition and Pursuing Development Through Quality: Qirui Pharmaceutical Successfully Holds Its 2024 Annual Quality Knowledge Competition
Category: News and Information
Release Date: 2024-06-28
Summary:
To fully implement Qirui Group’s core value of “Quality and Responsibility,” vigorously promote a culture of quality, and strengthen quality awareness across the organization, Qirui Pharmaceutical recently organized the 2024 Quality Knowledge Competition, themed “Quality Responsibility in Our Hearts, Product Quality in Our Hands.”
This competition is centered on knowledge related to the Drug Administration Law of the People’s Republic of China and the Good Manufacturing Practice for Pharmaceuticals. The event consists of a preliminary round and a final round. The preliminary round is conducted as an online knowledge quiz, in which all employees of Qirui Pharmaceutical actively participated. Following the online assessment, 18 outstanding contestants stood out thanks to their solid professional expertise and advanced to the final round.
Following the preliminary rounds that served as a warm-up, the final competition officially kicked off with strong support from company leadership and employees. This final round featured four distinguished industry experts serving as professional judges: Haiyang, Quality Director at Qirui Pharmaceutical; Lu Yan, Production Director; Liu Le, Manager of the Quality Assurance Department; and Fei Cairong, Deputy Manager of the Quality Control Department.
With the official start of the competition, the six teams squared off in three grueling rounds to determine the ultimate winner. The first round was a mandatory-answer segment, in which the teams drew cards to reveal their questions. Displaying composure and quick thinking, the contestants fully demonstrated their solid theoretical foundation and extensive knowledge. The second round was a buzzer-beater challenge, bringing the competition to a fever pitch: teams were highly motivated and firing on all cylinders, with participants scrambling to answer as soon as the question was posed, instantly igniting the atmosphere and pushing the score into a tight stalemate at times. In the third round, an open-response segment, the teams once again drew questions. Faced with complex scenarios, they unleashed their creativity, engaging in a collaborative brainstorming session to devise strategies before complementing and refining each other’s answers—clearly showcasing their rigorous logical reasoning and earning valuable points for their respective teams. Throughout the event, audience participation was also woven into the program, with spectators eagerly vying to answer and actively engaging, driving the atmosphere to one thrilling climax after another.



After a fiercely contested competition, Team 1—comprising Liu Li from the Quality Assurance Department, Wang Ying from the Quality Control Department, and Luo Min from the Pilot-Scale Research Platform—emerged as the champion; Team 3—consisting of Liu Xiaohao from the Production Department, Wang Qingling from the Quality Assurance Department, and Yi Jianfeng from the Quality Control Department—secured second place; and Team 6—made up of Cai Jing from the Process Technology Department, Liang Yunpeng from the Materials Department, and Yi Qun from the Quality Control Department—took third place. In addition to the team awards, the competition also presented individual honors to the contestants with the highest accuracy rates. Among them, Wang Ying from the Quality Control Department stood out and was ultimately awarded the title of “Quality Star.”

(First Prize) 
(Second Prize) 
(Third Prize) 
(Personal Award)
The 2024 Quality Knowledge Competition organized by Qirui Pharmaceutical has successfully concluded. This event deepened the company’s quality philosophy, strengthened employees’ knowledge of regulatory requirements, and fostered greater communication and collaboration across departments.

Correspondent | Tan Yingying
Keywords: Enhancing Competence Through Competition and Pursuing Development Through Quality: Qirui Pharmaceutical Successfully Holds Its 2024 Annual Quality Knowledge Competition
Related News Centers
Academic Column
Development History
-
2019
Release time:2023-01-05
-
2018
Release time:2023-01-05
-
2017
Release time:2023-01-05
-
2014
Release time:2023-01-05
-
2013
Release time:2023-01-05
-
2012
Release time:2023-01-05
-
2011
Release time:2023-01-05
-
2010
Release time:2023-01-05
-
2009
Release time:2023-01-05
-
2008
Release time:2023-01-05
-
2007
Release time:2023-01-05
-
2006
Release time:2023-01-05
-
2005
Release time:2023-01-05
-
2004
Release time:2022-12-30
-
2003
Release time:2022-12-30
Branch office
News and Information
-
Qirui Group’s First Innovative Drug, MY008211A Tablets (Lanocapam Hydrochloride Tablets), Successfully Achieves the Primary Efficacy Endpoint in Phase III Clinical Trials
Release time:2026-02-25
-
Qirui Group’s First Innovative Drug Passes Both National Key Inspections on the First Attempt
Release time:2026-01-27
-
Three Employees of Qirui Pharmaceutical Awarded Jiangxia District’s Tangxun Lake Talent Recognition!
Release time:2026-01-15
-
“A ‘Start’ That Stands Out, Bringing in Talented Young Professionals — Qirui Group’s 2026 Campus Recruitment Concludes Successfully”
Release time:2025-12-31
-
Qirui Pharmaceutical’s Ganyining® Ademetionine Disulfonate for Injection Wins Bid in the 11th National Centralized Procurement Round
Release time:2025-11-11
-
Qirui Group Makes Its Debut at the 17th Bio-Industry Conference
Release time:2025-09-08
-
Empowering Your Journey, Illuminating the Path Ahead—Qirui Group’s 2025 New Graduate Onboarding Program Concludes Successfully
Release time:2025-07-23
-
Internationally Accredited! Qirui Technology Earns ACCA Recognized Employer Status
Release time:2025-07-08
-
Safeguarding the Source of Life and Fortifying the Quality Defense Line for Pharmaceutical Water — Professional Training on Purified Water Systems at Qirui Pharmaceutical
Release time:2025-06-05
-
Wuhan Qirui Technology Development Co., Ltd. Donates RMB 100 Million to Huazhong University of Science and Technology
Release time:2025-03-17
-
People-Oriented, Win-Win Future | Qirui Pharmaceutical Honored as “2024 China’s Top Employer”
Release time:2025-02-18
-
Empowering Party Building to Unite New Forces, Achieve Synergy, and Expand “Health”
Release time:2024-07-10
-
Qirui Group Makes Its Debut at CPHI China 2024
Release time:2024-06-28
-
Enhancing Competence Through Competition and Pursuing Development Through Quality: Qirui Pharmaceutical Successfully Holds Its 2024 Annual Quality Knowledge Competition
Release time:2024-06-28
-
Shining with the Light of Wisdom, Passing on the Torch of Scholarship — The Joint Master’s Thesis Defense Ceremony between Qirui Pharmaceutical and China Pharmaceutical University Concludes Successfully
Release time:2024-06-07
-
Academic Gala | The 8th International Forum on Drug-Induced Liver Injury Concludes Successfully; Ornithine Aspartate Recommended in the “Chinese Guidelines for Primary Care Diagnosis and Management of Drug-Induced Liver Injury (2024)”
Release time:2024-05-31
-
Qirui Pharmaceutical Awarded the “Wuhan May Day Labor Medal”
Release time:2024-05-13
-
Qirui Pharmaceutical Selected for Inclusion in the 2023 Jiangxia District List of Proposed Projects for District-Level Technology Transfer and Key R&D Initiatives
Release time:2024-04-12
-
“Made in Wuhan” Generic Drugs Added to the 2020 National Reimbursement Drug List
Release time:2021-03-05
-
Congratulatory Letter to Shandong Ruiyin Bioengineering Co., Ltd.
Release time:2021-02-01
-
Douyin Live Stream Coverage | Qirui’s 2020 Annual Work Summary and Awards Ceremony Held Successfully!
Release time:2021-01-28
-
First Public Notice of the Environmental Impact Assessment for the Demonstration Project on the Transformation and Construction of a Multi-Functional, Intelligent, Safe, Green, and High-End Active Pharmaceutical Ingredient Production Platform and Pilot-Scale Service Platform at Wuhan Zhongyou Pharmaceutical Co., Ltd.
Release time:2020-06-28
-
Decision on Commending the 2020 Pioneers in Epidemic Prevention Responsibility and Model Workers in Resuming Work and Production
Release time:2020-05-11
-
Notice of the Renewal of the Employee Care and Corporate Culture Development Committee
Release time:2020-04-27
Sunshine Avenue, Sunshine Third Road, Miaoshan Subdistrict, Economic Development Zone, Jiangxia District, Wuhan, Hubei Province
QR code
Copyright © Wuhan Qirui Pharmaceutical Co., Ltd. |Privacy Policy
Powered by www.300.cn
This website supports IPv6.